1st Quarter - Report

SPECIALTY TOBACCO COUNCIL, INC. for SPECIALTY TOBACCO COUNCIL INC

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report (this page) Jun 3, 2025 — Replaced
1st Quarter - Report Jun 3, 2025 — Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Tobacco TOB

FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry

Foreign entity interest: PT Djarum, identified on LD-1, exports tobacco products to the United States and is impacted by FDA regulation of tobacco.

LobbyistCovered position, as disclosed
HENRY ROEMER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Trade (domestic/foreign) TRD

To ensure FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissible restrictions on trade, PL 111-31.

Foreign entity interest: PT Djarum, identified on LD-1, exports tobacco products to the United States and is impacted by FDA regulation of tobacco.

LobbyistCovered position, as disclosed
HENRY ROEMER —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.